Found: 117
Select item for more details and to access through your institution.
Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2647, doi. 10.1007/s00277-023-05287-2
- By:
- Publication type:
- Article
Force‐sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 780, doi. 10.1111/hae.14987
- By:
- Publication type:
- Article
Smaller household size and higher prevalence of serious psychological distress in younger people and never-married people: a nationwide cross-sectional survey in Japan.
- Published in:
- Frontiers in Public Health, 2024, p. 01, doi. 10.3389/fpubh.2024.1292371
- By:
- Publication type:
- Article
Terminus‐Selective Covalent Immobilization of Heparin on a Thermoresponsive Surface Using Click Chemistry for Efficient Binding of Basic Fibroblast Growth Factor.
- Published in:
- Macromolecular Bioscience, 2024, v. 24, n. 2, p. 1, doi. 10.1002/mabi.202300307
- By:
- Publication type:
- Article
Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 106, doi. 10.1111/hae.14895
- By:
- Publication type:
- Article
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 6, p. 690, doi. 10.1007/s12185-023-03667-y
- By:
- Publication type:
- Article
Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 6, p. 699, doi. 10.1007/s12185-023-03668-x
- By:
- Publication type:
- Article
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study.
- Published in:
- Thrombosis Journal, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12959-023-00511-5
- By:
- Publication type:
- Article
Current and future therapies for haemophilia—Beyond factor replacement therapies.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 23, doi. 10.1111/bjh.18379
- By:
- Publication type:
- Article
Anti‐idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 329, doi. 10.1111/hae.14662
- By:
- Publication type:
- Article
Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 1, p. 56, doi. 10.1007/s12185-022-03468-9
- By:
- Publication type:
- Article
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 694, doi. 10.1111/hae.14581
- By:
- Publication type:
- Article
Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 423, doi. 10.1007/s12185-022-03359-z
- By:
- Publication type:
- Article
Heterogeneous coagulant potential of emicizumab in neonatal factor VIII–deficient plasma.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 7, p. 1, doi. 10.1002/pbc.29731
- By:
- Publication type:
- Article
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 4, p. 489, doi. 10.1007/s12185-021-03276-7
- By:
- Publication type:
- Article
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 2, p. 163, doi. 10.1007/s12185-021-03249-w
- By:
- Publication type:
- Article
Occupational status and self-reported low back pain by gender: a nation-wide cross-sectional study among the general population in Japan.
- Published in:
- Environmental Health & Preventive Medicine, 2021, v. 26, n. 1, p. 1, doi. 10.1186/s12199-021-01031-2
- By:
- Publication type:
- Article
Fraction and Number of Unemployed Associated with Self-Reported Low Back Pain: A Nation-Wide Cross-Sectional Study in Japan.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 20, p. 10760, doi. 10.3390/ijerph182010760
- By:
- Publication type:
- Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 854, doi. 10.1111/hae.14363
- By:
- Publication type:
- Article
Mental component of health-related quality of life is an independent predictor of incident functional disability among community-dwelling older people: a prospective cohort study.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 7, p. 1853, doi. 10.1007/s11136-021-02780-x
- By:
- Publication type:
- Article
Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan.
- Published in:
- Harm Reduction Journal, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12954-021-00469-5
- By:
- Publication type:
- Article
Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear condition.
- Published in:
- Haemophilia, 2021, v. 27, n. 2, p. e194, doi. 10.1111/hae.14272
- By:
- Publication type:
- Article
Successful unrelated cord blood transplantation for Diamond–Blackfan anemia.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Substitution therapy.
- Published in:
- Haemophilia, 2021, v. 27, p. 53, doi. 10.1111/hae.14072
- By:
- Publication type:
- Article
A microchip flow‐chamber assay screens congenital primary hemostasis disorders.
- Published in:
- Pediatrics International, 2021, v. 63, n. 2, p. 160, doi. 10.1111/ped.14378
- By:
- Publication type:
- Article
Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio.
- Published in:
- Clinical Pediatric Endocrinology, 2021, v. 30, n. 1, p. 19, doi. 10.1297/cpe.30.19
- By:
- Publication type:
- Article
Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 81, doi. 10.1111/hae.14205
- By:
- Publication type:
- Article
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 966, doi. 10.1111/hae.14144
- By:
- Publication type:
- Article
Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1009, doi. 10.1111/hae.14183
- By:
- Publication type:
- Article
A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 5, p. 621, doi. 10.1007/s12185-020-02959-x
- By:
- Publication type:
- Article
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis‐treated haemophilia A patients with inhibitors.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 5, p. 727, doi. 10.1111/bjh.16574
- By:
- Publication type:
- Article
Plasma-derived factors VIIa and X mixtures (Byclot<sup>®</sup>) significantly improve impairment of coagulant potential ex vivo in plasmas from acquired hemophilia A patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Emicizumab improves the stability and structure of fibrin clot derived from factor VIII‐deficient plasma, similar to the addition of factor VIII.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. e97, doi. 10.1111/hae.13961
- By:
- Publication type:
- Article
Assessment of self‐/parent‐reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN‐52.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. 243, doi. 10.1111/hae.13945
- By:
- Publication type:
- Article
Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical utility and impact of the use of the chromogenic vs one‐stage factor activity assays in haemophilia A and B.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 1, p. 3, doi. 10.1111/ejh.13339
- By:
- Publication type:
- Article
Current progress and future direction in the treatment for hemophilia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A novel simultaneous clot‐fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 518, doi. 10.1111/bjh.16111
- By:
- Publication type:
- Article
A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 6, p. 979, doi. 10.1111/hae.13848
- By:
- Publication type:
- Article
Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pulmonary hypertension with diffuse lung lesions in cobalamin C defect.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation.
- Published in:
- Pediatrics International, 2019, v. 61, n. 9, p. 872, doi. 10.1111/ped.13919
- By:
- Publication type:
- Article
Hemostatic assessment of combined anticoagulant therapy using warfarin and prothrombin complex concentrates in a case of severe protein C deficiency.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial).
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 373, doi. 10.1111/hae.13712
- By:
- Publication type:
- Article
Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS).
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 382, doi. 10.1111/hae.13731
- By:
- Publication type:
- Article
Whole blood ristocetin‐induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. e174, doi. 10.1111/hae.13725
- By:
- Publication type:
- Article
Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
- Published in:
- 2019
- By:
- Publication type:
- journal article